Global Autologous Cell Therapy Market Forecasted To Grow At A CAGR Of 23.39% Between The Period 2017 - 2021

Researchmoz added Most up-to-date research on "Global Autologous Cell Therapy Market Forecasted To Grow At A CAGR Of 23.39% Between The Period 2017 - 2021" to its huge collection of research reports.

Autologous cell therapy belongs to the field of regenerative medicine and is based on biologic cell-based therapies to cure various diseases, including those of oncology, neurology, and dermatology, to name a few. Autologous cell therapy is one of the fastest growing segments of regenerative medicine and hence, is attracting significant research funds from various quarters.

Technavios analysts forecast the global autologous cell therapy market to grow at a CAGR of 23.39% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global autologous cell therapy market for 2017-2021. To calculate the market size, the report considers the sales of autologous stem cell as well non-stem cell products.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Autologous Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1140762

Key vendors
Brainstorm Cell Therapeutics
Holostem Advanced Therapies
Osiris Therapeutics
Valeant
Vericel Corporation

Other prominent vendors
AbbVie
American CryoStem
AM-Pharma
Anterogen
apceth Biopharma
Astellas Pharma
Athersys
Baxter International
Beike Biotechnology
BIOTIME
bluebird bio
Bristol-Myers Squibb
Brainxell
Caladrius Biosciences
Cellular Biomedicine Group
Cellular Dynamics International (a subsidiary of Fujifilm)
Cesca Therapeutics
CHA Biotech
Chugai Pharmaceutical
Citospin
Corestem
Cytori Therapeutics
Daiichi Sankyo
Fujifilm
Gamida Cell
Global Stem Cells Group
Grupo Ferrer Internacional
GlaxoSmithKline
Hemostemix
Histocell
International Stem Cell
Ivy Institute of Stem Cells
Japan Regenerative Medicine
Kangstem Biotech
Kiadis Pharma
Laboratorios Salvat
MEDIPOST
Mesoblast
Nuo Therapeutics
Opsis Therapeutics
Pharmicell
Pluristem Therapeutics
Promethera Biosciences
Q Therapeutics
ReNeuron
RHEACELL
Salus Medical Solutions
Sangamo Therapeutics
Shire
Steminent Biotherapeutics
Sumitomo Dainippon Pharma
Taiwan Bio Therapeutics
Takeda Pharmaceutical
Teva Pharmaceutical Industries
Thoratec Corporation
TiGenix
Translational Biosciences
TWO CELLS
U.S. Stem Cell
ViaCyte
VistaGen Therapeutics

Browse TOC @ https://www.researchmoz.us/global-autologous-cell-therapy-market-2017-2021-report.html/toc

Market driver
Increasing demand for effective drugs for cardiac and degenerative disorders
For a full, detailed list, view our report

Market challenge
Critical ethical challenges with respect to stem cell research
For a full, detailed list, view our report

Market trend
Private funding will fuel market growth
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?